Nosocomial pneumonia: More than just ventilator-associated
- 38 Downloads
We reviewed literature published from 1995 through 2000 on developments in ventilator-associated pneumonia. There is no gold standard with which to compare the accuracy of various invasive procedures performed for diagnosis. Moreover, leaders in the field are calling for an outcomes-based analysis to assess the utility of invasive procedures. Two things are clear: 1) adequate empiric therapy is beneficial, and 2) changes in therapy based on recovery of pathogens by invasive means do not affect outcome. Clinicians are urged to review local antimicrobial resistance patterns and to initiate empiric therapy on the basis of those data.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.National Nosocomial Infections Surveillance Program.Monitoring hospital acquired infections to promote patient safety. United States 1990–1999. MMWR Morb Mortal Wkly Rep 2000, 49:149–153.Google Scholar
- 5.Heyland DK, Cook DJ, Marshall J, et al.: The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Chest 1999, 115:1076–1084.The authors report that the greatest utility of bronchoscopic invasive testing is in helping clinicians confirm the presence or absence of nosocomial pneumonia. In patients found not to have pneumonia, antibiotic therapy could be promptly stopped.PubMedCrossRefGoogle Scholar
- 6.Fagon J-Y, Chastre J, Wolff M, et al.: Invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 2000, 132:621–630.These authors found that an invasive management strategy was associated with fewer deaths at 14 days, less organ dysfunction, and fewer days of antibiotics. Clinically managed patients were more likely to have microbial pathogens recovered from sputum and polymicrobial infections.Google Scholar
- 11.Torres A, El-Ebiary M: Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 2000, 117(suppl):198S-202S.Google Scholar
- 14.American Thoracic Society: Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 1996, 153:1711–1725.Google Scholar
- 17.Kollef M, Ward S: The influence of mini-BAL cultures on patient outcomes. Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998, 113:412–420.These authors report the most important determinant of outcome for patients with suspected VAP is antibiotic selection before obtaining results from lower airway sampling.PubMedCrossRefGoogle Scholar
- 25.Hammer DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000, 162:328–330.Google Scholar
- 27.Cook DJ, Walter SD, Cook RJ, et al.: Incidence of and risk factors for ventilator associated pneumonia in critically ill patients. Ann Intern Med 1998, 129:433–440.A large prospective study that identified risk factors for acquisition of VAP, some of which are potentially modifiable.PubMedGoogle Scholar
- 38.Gruson D, Hilbert G, Vargas F, et al.: Rotation and restricted use of antibiotics in a medical intensive care unit. Am J Respir Crit Care Med 2000, 162:837–843.Google Scholar